Literature DB >> 1791144

Laryngeal precancer: a review of the literature, commentary, and comparison with oral leukoplakia.

J E Bouquot1, D R Gnepp.   

Abstract

Laryngeal keratosis (LK) is a precancerous mucosal change with great similarity to oral leukoplakia. Its malignant transformation rate varies from 1% to 40%, with the highest rates being found in patients microscopically diagnosed as "keratosis with atypia" (KWA). Recent evidence indicates that even cases with only mild or moderate epithelial dysplasias are at increased risk for malignant transformation, with the highest rates occurring in patients with more severe dysplasia or carcinoma in situ. Approximately 81% of LK patients are men and the average age at diagnosis is 50 years, a decade younger than that for laryngeal carcinoma patients. A high proportion of LK patients are tobacco smokers (84%) and alcohol abusers (at least 35%). LK is almost always found on the true vocal cords and is usually bilateral (67%). Clinical signs of high risk include, in decreasing order of importance: erythroplakia, surface granularity, increased keratin thickness, increased size, recurrence after conservative removal, and long duration. The annual incidence of LK in the United States is 10.2 and 2.1 lesions per 100,000 males and females, respectively.

Entities:  

Mesh:

Year:  1991        PMID: 1791144     DOI: 10.1002/hed.2880130604

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  14 in total

1.  Predictive factors of recurrence and malignant transformation in vocal cord leukoplakia.

Authors:  Dong Hoon Lee; Tae Mi Yoon; Joon Kyoo Lee; Sang Chul Lim
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-03-08       Impact factor: 2.503

2.  MicroRNA-10a-5p and microRNA-34c-5p in laryngeal epithelial premalignant lesions: differential expression and clinicopathological correlation.

Authors:  Yanping Hu; Honggang Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-09-30       Impact factor: 2.503

Review 3.  Management of laryngeal dysplasia: a review.

Authors:  Maziar Sadri; Jeremy McMahon; Andrew Parker
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-07-06       Impact factor: 2.503

Review 4.  Current understanding of the tumor microenvironment of laryngeal dysplasia and progression to invasive cancer.

Authors:  Sumita Trivedi; Clark A Rosen; Robert L Ferris
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2016-04       Impact factor: 2.064

5.  Association of laryngeal cancer with vocal cord leukoplakia and associated risk factors in 1,184 patients diagnosed in otorhinolaryngology practices in Germany.

Authors:  Karel Kostev; Louis E C Jacob; Matthias Kalder; Andreas M Sesterhenn; David Ulrich Seidel
Journal:  Mol Clin Oncol       Date:  2018-03-21

6.  Treatment outcome of vocal cord leukoplakia by transoral laser microsurgery.

Authors:  Shih-Wei Yang; Wei-Chieh Chao; Yun-Shien Lee; Liang-Che Chang; Tsan-Yu Hsieh; Tai-An Chen; Cheng-Ming Luo
Journal:  Lasers Med Sci       Date:  2016-09-29       Impact factor: 3.161

7.  Serial full-thickness excision of dysplastic vocal fold leukoplakia: Diagnostic or therapeutic?

Authors:  Annie Ahn; Li Wang; James C Slaughter; Amy M Nguyen; Robert H Ossoff; David O Francis
Journal:  Laryngoscope       Date:  2015-11-03       Impact factor: 3.325

8.  The role of narrow-band imaging (NBI) endoscopy in optical biopsy of vocal cord leukoplakia.

Authors:  L Staníková; J Šatanková; H Kučová; R Walderová; K Zeleník; Pavel Komínek
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-08-11       Impact factor: 2.503

9.  Glottic Keratosis: Significance and Identification of Laryngoscopic Findings.

Authors:  Mursalin M Anis; Jennylee Diaz; Mausam Patel; Adam T Lloyd; David E Rosow
Journal:  OTO Open       Date:  2021-02-25

Review 10.  European Laryngological Society position paper on laryngeal dysplasia Part I: aetiology and pathological classification.

Authors:  Edward Odell; Hans Edmund Eckel; Ricard Simo; Miquel Quer; Vinidh Paleri; Jens Peter Klussmann; Marc Remacle; Elisabeth Sjögren; Cesare Piazza
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-10-13       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.